Friendly reminder
This product is supplied in a pure, lyophilized (freeze-dried) form. Bacteriostatic Water is required for reconstitution.
Investigational triple-agonist research
Triple Agonist RT
Investigational status, stated without ambiguity.
Triple Agonist RT is a novel synthetic peptide and investigational triple agonist that simultaneously targets the GLP-1, GIP, and glucagon receptors.
Research use only · Not for human consumptionCurrent price$100.00
In stock
Research vial
Quantity
Investigational research material. Not an approved consumer treatment and not for human consumption.1
Research context
Clear information before ordering.
Published and sponsor-reported clinical-trial findings for the developer’s investigational retatrutide compound have reported substantial body-weight reductions and improvements in glycemic measures among studied participants. Researchers have also examined appetite signaling, insulin sensitivity, fat mass, and body composition. Retatrutide remains investigational, and those findings do not establish that this AURA research material is equivalent to the compound used in clinical trials or guarantee its safety, effectiveness, weight-loss results, fat reduction, muscle preservation, body recomposition, glycemic control, or any individual outcome.
Before ordering
Research information and terms.
Research-only use
This material is sold strictly for in vitro laboratory research use only. It is not intended for human consumption, clinical use, or veterinary applications. No claims are made regarding safety or efficacy for therapeutic purposes.
Disclaimer
The information presented here is provided for scientific and educational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA or any regulatory authority. Product use is restricted to qualified researchers in compliance with local, state, and federal law.
Terms of sale
By purchasing this item, you confirm that you are a qualified individual or laboratory operating within appropriate research guidelines. All liability and responsibility for handling, use, or misuse of this product rest solely with the buyer.
Product status
Investigational compound — not an approved consumer treatment. This listing does not represent an approved therapeutic indication.
Product format
Research reference material. Verify the final label, net quantity, and batch identity before accepting the material.
Documentation
Request batch-specific identity, purity, and testing documentation from support when available.
Storage
Follow only the verified label and batch documentation. Contact support if product-specific storage information is not supplied.
Product questions
About Triple Agonist RT
Straight answers, responsible limits, and a direct path to support.
No. This listing is educational and research-focused and does not present the material as an approved treatment.